Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

cbdMD (YCBD) EBIAT (2016 - 2025)

cbdMD's EBIAT history spans 10 years, with the latest figure at -$283131.0 for Q4 2025.

  • On a quarterly basis, EBIAT fell 1975.66% to -$283131.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.3 million, a 13.0% increase, with the full-year FY2025 number at -$2.0 million, up 44.84% from a year prior.
  • EBIAT hit -$283131.0 in Q4 2025 for cbdMD, up from -$679968.0 in the prior quarter.
  • Over the last five years, EBIAT for YCBD hit a ceiling of $1.5 million in Q2 2021 and a floor of -$31.6 million in Q2 2022.
  • Historically, EBIAT has averaged -$5.7 million across 5 years, with a median of -$1.6 million in 2023.
  • Biggest five-year swings in EBIAT: plummeted 2157.79% in 2022 and later surged 125.97% in 2024.
  • Tracing YCBD's EBIAT over 5 years: stood at -$19.2 million in 2021, then skyrocketed by 79.35% to -$4.0 million in 2022, then skyrocketed by 74.81% to -$996501.0 in 2023, then surged by 101.51% to $15095.0 in 2024, then crashed by 1975.66% to -$283131.0 in 2025.
  • Business Quant data shows EBIAT for YCBD at -$283131.0 in Q4 2025, -$679968.0 in Q3 2025, and -$895272.0 in Q2 2025.